NSE:GLENMARK

Glenmark Pharmaceuticals Stock Predictions

Healthcare > Drug Manufacturers - Specialty & Generic

Buy GLENMARK

*Your capital is at risk

₹2,174.00

-10.60 (-0.485%)

At Close: Jun 03, 2026

Currently predicting for Fri, 5 Jun 2026

GLENMARK.NS Prediction Chart

GLENMARK.NS Predictions History

Latest community submissions for GLENMARK.NS.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
leafdougal007.384333	Jul 24, 2023	Bullish	₹788.30	V	—	1
JS Pro	May 10, 2023	₹571.50 +0.45%	₹569.95	V	99.73%	5
PredictionBot.Kathy Pro	May 10, 2023	₹563.75 -0.91%	₹569.95	X	98.91%	1
PredictionBot.Warren Pro	May 10, 2023	₹565.70 -0.57%	₹569.95	X	99.25%	3

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for GLENMARK.NS with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT GLENMARK PHARMACEUTICALS LIMITED

Glenmark Pharmaceuticals Limited, together with its subsidiaries, develops, manufactures, and markets pharmaceutical products in India, North America, Latin America, Europe, and internationally. The company provides branded and generic formulations in the therapeutic areas of dermatology, respiratory, and oncology; and various active pharmaceutical ingredients. Its product pipeline includes ISB 830 (telazorlimab), an OX40 antagonist monoclonal an...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by